SCHEMBL8287906

SCHEMBL8287906

Cc1ccccc1Nc1cc(=O)c2cc(F)c(N3CCCCC3)nc2n1-c1ccccc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 7/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ALDH1A1 P00352 7/20 0.36
ATM Q13315 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
PDE9A O76083 1/20 0.35
MAPK1 P28482 3/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
GBA1 P04062 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
AKT1 P31749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287898 0.87 LMNA (0.38) L3MBTL1MAPTALDH1A1KDM4EHTT
SCHEMBL8287937 0.82 DHODH (0.32) L3MBTL1MAPTNPSR1ALDH1A1KDM4E
SCHEMBL8285121 0.82 ALDH1A1 (0.39) L3MBTL1MAPTNPSR1ALDH1A1KDM4E
SCHEMBL8287901 0.77 MAPT (0.48) POLBMAPTNPSR1ALDH1A1KDM4E
SCHEMBL8287907 0.73 EGFR (0.41) MAPTNPSR1ALDH1A1KDM4EMAPK1
SCHEMBL8287909 0.72 MAPT (0.44) L3MBTL1POLBMAPTNPSR1ALDH1A1
SCHEMBL6801451 0.69 LMNA (0.39) L3MBTL1POLBMAPTNPSR1ALDH1A1
SCHEMBL8285179 0.69 PDE11A (0.58) MAPTALDH1A1ATMKDM4EHTT
SCHEMBL8285122 0.68 SMN1; SMN2 (0.36) MAPTNPSR1ALDH1A1KDM4EMAPK1
SCHEMBL8286382 0.67 PDE11A (0.44) ALDH1A1ATMMAPK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed